MedTech News
.................... by Andrew Celentano
A molecular ‘switch’ could make pancreatic cancer more treatable
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some of the most treatment-resistant tumors into forms that are more manageable with existing drugs.
Painless skin patch offers new way to monitor immune health
Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have developed the first bandage-like microneedle patch that can sample the body’s immune responses painlessly from the skin.
Abbott wins FDA approval for updated heart failure monitoring device
The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.
Novocure has reimbursement win for Optune Lua in Japan
Novocure (Nasdaq:NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved reimbursement for its Optune Lua system.
Boston Scientific wins expanded CE mark for Farapulse in persistent AFib
Boston Scientific (NYSE: BSX)+ announced today that its Farapulse pulsed field ablation (PFA) system received expanded CE mark approval.
BD earns FDA 510(k) clearance for Surgiphor 1000mL system
BD (NYSE: BDX)+ received FDA 510(k) clearance for its Surgiphor 1000mL antimicrobial irrigation system, the company announced today.
Senseonics earns FDA IDE for next-gen Gemini CGM, posts Q4 revenue beat
Senseonics (NYSE:SENS) posted fourth-quarter results that proved mixed compared to Wall Street forecasts alongside a major pipeline announcement.
SciBase receives approval by FDA for extended labelling in the US
STOCKHOLM, March 2, 2026 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received approval by FDA for its supplement to extend the labelling to include other healthcare professionals and not only dermatologists to perform the Nevisense procedure